These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2672243)

  • 61. Effect of paclitaxel alone or in combination on the intracellular penetration and activity of quinolones in human neutrophils.
    García I; Pascual A; Salvador J; Conejo MC; Perea EJ
    J Antimicrob Chemother; 1996 Nov; 38(5):859-63. PubMed ID: 8961056
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Use of quinolones in urinary tract infections and prostatitis.
    Naber KG
    Rev Infect Dis; 1989; 11 Suppl 5():S1321-37. PubMed ID: 2672257
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetic aspects of newer quinolones.
    Uematsu T; Nakashima M
    Prog Drug Res; 1992; 38():39-55. PubMed ID: 1609117
    [No Abstract]   [Full Text] [Related]  

  • 64. Penetration of antimicrobial agents into the prostate.
    Charalabopoulos K; Karachalios G; Baltogiannis D; Charalabopoulos A; Giannakopoulos X; Sofikitis N
    Chemotherapy; 2003 Dec; 49(6):269-79. PubMed ID: 14671426
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [New quinolones: similarities and differences].
    Levi GC
    AMB Rev Assoc Med Bras; 1989; 35(5):202-6. PubMed ID: 2486418
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pefloxacin clinical pharmacokinetics.
    Bressolle F; Gonçalves F; Gouby A; Galtier M
    Clin Pharmacokinet; 1994 Dec; 27(6):418-46. PubMed ID: 7882634
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical role of protein binding of quinolones.
    Bergogne-Bérézin E
    Clin Pharmacokinet; 2002; 41(10):741-50. PubMed ID: 12162760
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antimicrobial susceptibility of Salmonella typhi to quinolones & cephalosporins.
    Bhat KG; Andrade AT; Karadesai SG; Hemashettar BM; Patil CS
    Indian J Med Res; 1998 Jun; 107():247-51. PubMed ID: 9701891
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Penetration of lomefloxacin into bronchial secretions following single and multiple oral administration.
    Bergogne-Bérézin E; Muller-Serieys C; Kafé H
    Am J Med; 1992 Apr; 92(4A):8S-11S. PubMed ID: 1316076
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
    Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
    Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The in-vitro susceptibilities of 326 Streptococcus pneumoniae isolates to nine antimicrobial agents including penicillin and newer quinolones.
    Loo VG; Lavellée J; McAlear D; Robson HG
    J Antimicrob Chemother; 1994 Mar; 33(3):641-5. PubMed ID: 8040129
    [No Abstract]   [Full Text] [Related]  

  • 72. Intraocular dynamic mode differences of new quinolone antibacterial agents between pigmented and albino rabbit eyes.
    Fukuda M; Sasaki K
    Lens Eye Toxic Res; 1989; 6(1-2):339-51. PubMed ID: 2488026
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New quinolones in clinical practice.
    Gould IM
    Hosp Med; 1999 Apr; 60(4):309. PubMed ID: 10419336
    [No Abstract]   [Full Text] [Related]  

  • 74. Comparison of the pharmacodynamic properties of quinolones.
    Wiedemann B; Rustige-Wiedemann C; Kratz B
    Drugs; 1995; 49 Suppl 2():269-71. PubMed ID: 8549328
    [No Abstract]   [Full Text] [Related]  

  • 75. [Lomefloxacin concentration in human prostatic tissue following 3-day administration].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1993 Jan; 39(1):97-9. PubMed ID: 7681621
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antimicrobial therapy: past, present, and future.
    Ronald AR
    Clin Invest Med; 1989 Feb; 12(1):3-6. PubMed ID: 2920480
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enrofloxacin concentrations in dogs with normal prostate and dogs with chronic bacterial prostatitis.
    Dorfman M; Barsanti J; Budsberg SC
    Am J Vet Res; 1995 Mar; 56(3):386-90. PubMed ID: 7771709
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New antibiotics: carbapenems, monobactams and quinolones.
    Amin NM
    Am Fam Physician; 1988 Oct; 38(4):125-34. PubMed ID: 3051970
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (1994). III. Secular changes in susceptibility].
    Kumamoto Y; Hirose T; Yokoo A; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Tazaki H; Iri H; Uchida H; Kobayashi Y; Matsuda S; Fujime M; Fujita K; Kitagawa R; Igari J; Oguri T; Kosakai N; Yamaguchi K; Kashitani F; Yonezu S; Yamanaka Y; Takaha M; Iori F
    Jpn J Antibiot; 1996 Jun; 49(6):555-657. PubMed ID: 8776631
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metabolism of gyrase inhibitors.
    Sörgel F
    Rev Infect Dis; 1989; 11 Suppl 5():S1119-29. PubMed ID: 2549606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.